Clinical Trial

Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions

Name: Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions — clinical trial record (NCT07090525)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to explore the efficacy and safety ofof bevacizumab plus cisplatin compare with cisplatin in the treatment of malignant serous effusion in patients with advanced adenocarcinoma

Trial Details

NCT Number	NCT07090525
Lead Sponsor	Qingdao Central Hospital
Conditions	Overall Response Rate
Enrollment	60 participants
Start Date	2025-07-01
Primary Completion	2026-12-01 (estimated)
Study Completion	2027-05-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-29